Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) announced that John H. Johnson, Chief Executive Officer and President of Savient will present at the Sixth Annual JMP Securities Healthcare Conference on Wednesday, September 28, 2011 at 9:30 a.m. Eastern Time. The conference will be held at the St. Regis hotel in New York City.

Savient Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing KRYSTEXXA, a biologic PEGylated uricase in the United States.

Read the full article and the disclaimer at: http://bestotc.com/18312/stock-alerts/svnt-spns-mjgcfpk-elmd-featured-st...